International Clinical Trial: Changes for Australian Paediatric Patients In the Treatment of Acute Lymphoblastic Leukaemia (CAPITALL), A comparison study measuring the effectiveness of an alternative treatment schedule incorporating earlier blinatumomab and standard treatment

Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ACTRN12626000900314) titled 'Changes for Australian Paediatric Patients In the Treatment of Acute Lymphoblastic Leukaemia (CAPITALL), A comparison study measuring the effectiveness of an alternative treatment schedule incorporating earlier blinatumomab and standard treatment' on July 21.

Study Type: Interventional

Study Design: Purpose: Treatment Allocation: Non-randomised trial Masking: Open (masking not used) Assignment: Other Type of endpoint: Safety/efficacy

Primary Sponsor: University of New South Wales - Sydney

Condition: Acute Lymphoblastic Leukaemia Acute Lymphoblastic Leukaemia Cancer - Leukaemia - Acute leukaemia Cancer - Ch...